Luke S McLean

7PUBLICATIONS
11CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Cancer geneticsPredictive and prognostic markersChemotherapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jan 29, 2026
Cemiplimab in the treatment of cutaneous squamous cell carcinoma.

Luke S McLean, Annette M Lim, Danny Rischin

|Apr 13, 2024
Optimising Patient Outcomes in Tongue Cancer: A Multidisciplinary Approach.

Jasper de Boer, Rebecca Barnett, Anthony Cardin

|Mar 19, 2024
Assessment of perineural spread in advanced cutaneous squamous cell carcinomas treated with immunotherapy.

Karda Cavanagh, Luke S McLean, Annette M Lim

|Jan 11, 2024
Immune checkpoint inhibitor therapy for advanced cutaneous squamous cell carcinoma in Australia: a retrospective real world cohort study.

Luke S McLean, Annette M Lim, Mathias Bressel

|Jan 07, 2022
Standard-Dose Osimertinib in EGFR-Mutated Non-Small-Cell Lung Adenocarcinoma With Leptomeningeal Disease.

Luke S McLean, Wasek Faisal, Sagun Parakh

Pageof 2